Lextrading

200sma support on the weekly (hopefully).

NASDAQ:EDIT   Editas Medicine, Inc.
$26.54
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.